Terms: = Kidney tumors AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
91 results:
1. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
2. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.
Khaleel S; Truong H; Jiang S; K-Lee P; Davelman B; Gordon D; Benfante N; Arora A; Ostrovnaya I; Tickoo S; Coleman J; Hakimi AA; Russo P
Urol Oncol; 2023 Sep; 41(9):391.e5-391.e11. PubMed ID: 37423816
[TBL] [Abstract] [Full Text] [Related]
3. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic role of cigarette smoking in kidney Cancer Survival.
Baral A; Cranford HM; Sharma J; Pinheiro PS
Cancer Med; 2023 Jul; 12(13):14756-14766. PubMed ID: 37199389
[TBL] [Abstract] [Full Text] [Related]
5. Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
de Velasco G; Alonso-Gordoa T; Rodríguez-Vida A; Anguera G; Campayo M; Pinto Á; Ortega EM; Gallardo E; Núñez NF; García-Carbonero I; Reig O; Méndez-Vidal MJ; Fernández-Calvo O; Cassinello NV; Torregrosa D; López-Martín A; Rosero A; Valiente PG; de España CG; Climent MA; Santasusana MD; Sánchez ÁR; González IC; Afonso R; García Del Muro X; Casinello J; Fernández-Parra EM; García Sánchez L; Afonso J; Polo SH; Asensio Ú
Clin Genitourin Cancer; 2023 Jun; 21(3):e166-e174. PubMed ID: 36610891
[TBL] [Abstract] [Full Text] [Related]
6. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.
Lichtensztajn DY; Hofer BM; Leppert JT; Brooks JD; Chung BI; Shah SA; DeRouen MC; Cheng I
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):202-207. PubMed ID: 36480301
[TBL] [Abstract] [Full Text] [Related]
7. Characterization of Outcomes by Surgical Management of Lung Neuroendocrine tumors Associated With Cushing Syndrome.
Seastedt KP; Alyateem GA; Pittala K; Steinberg SM; Schrump DS; Nieman LK; Hoang CD
JAMA Netw Open; 2021 Sep; 4(9):e2124739. PubMed ID: 34586369
[TBL] [Abstract] [Full Text] [Related]
8. Somatic-type Malignancies in Testicular Germ Cell tumors: A Clinicopathologic Study of 63 Cases.
Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.
Uemura M; Nakaigawa N; Sassa N; Tatsugami K; Harada K; Yamasaki T; Matsubara N; Yoshimoto T; Nakagawa Y; Fukuyama T; Oya M; Shinohara N; Uemura H; Tsuzuki T
Int J Clin Oncol; 2021 Nov; 26(11):2073-2084. PubMed ID: 34291367
[TBL] [Abstract] [Full Text] [Related]
10. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lamarca A; Palmer DH; Wasan HS; Ross PJ; Ma YT; Arora A; Falk S; Gillmore R; Wadsley J; Patel K; Anthoney A; Maraveyas A; Iveson T; Waters JS; Hobbs C; Barber S; Ryder WD; Ramage J; Davies LM; Bridgewater JA; Valle JW;
Lancet Oncol; 2021 May; 22(5):690-701. PubMed ID: 33798493
[TBL] [Abstract] [Full Text] [Related]
11. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract] [Full Text] [Related]
12. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.
Weng S; DiNatale RG; Silagy A; Mano R; Attalla K; Kashani M; Weiss K; Benfante NE; Winer AG; Coleman JA; Reuter VE; Russo P; Reznik E; Tickoo SK; Hakimi AA
Eur Urol; 2021 Apr; 79(4):468-477. PubMed ID: 33046271
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
Pei Y; Li Y; Liang Y; Xu L; Huang X; Li Y; Tang W; Jiang X
Int J Clin Pharm; 2020 Dec; 42(6):1440-1446. PubMed ID: 32974856
[TBL] [Abstract] [Full Text] [Related]
14. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
[TBL] [Abstract] [Full Text] [Related]
15. Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.
Baisakh MR; Tiwari A; Gandhi JS; Naik S; Sharma SK; Balzer BL; Sharma S; Peddinti K; Jha S; Sahu PK; Pradhan D; Geller M; Amin MB; Dhillon J; Mohanty SK
Hum Pathol; 2020 Oct; 104():84-95. PubMed ID: 32798549
[TBL] [Abstract] [Full Text] [Related]
16. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC
Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446
[TBL] [Abstract] [Full Text] [Related]
17. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
18.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
19. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
[TBL] [Abstract] [Full Text] [Related]
20. Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
Hu R; Gupta R; Wang Z; Wang C; Sun H; Singamaneni S; Kharasch ED; Morrissey JJ
Kidney Int; 2019 Dec; 96(6):1417-1421. PubMed ID: 31668633
[TBL] [Abstract] [Full Text] [Related]
[Next]
